Celator Pharmaceuticals celatorpharma.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identifies molar ratios of drugs that will deliver a synergistic benefit, and locks the desired ratio in a nano-scale drug delivery vehicle that maintains the ratio in patients with the goal of improving clinical outcomes. The company pipeline includes two clinical stage products; CPX-351 (a liposomal form...Show all

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identifies molar ratios of drugs that will deliver a syne...Show all

Company (Acquired)

Phone: 609-243-0123

Fax:

303B College Road East

Princeton, 08540
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Celator Pharmaceuticals $156.3M Jul 13, 2016
Cequent Pharmaceuticals $16.9M Apr 1, 2010
Novacea $100.8M May 10, 2006
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Celator Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Assays and methods for selecting a treatment regimen for a subject with leukemia Nov 10, 2016 Feb 23, 2021 Patent
Particulate constructs for release of active agents May 29, 2013 Feb 02, 2021 Patent
Method of lyophilizing liposomes Nov 05, 2018 Nov 17, 2020 Patent
Compositions for delivery of drug combinations Jul 27, 2018 Jul 28, 2020 Patent
Improved nanoparticle delivery systems Jul 14, 2016 May 14, 2019 Patent
See all 24 patents